"Many people speculated that the SARAH study, reported today, was going to miss it's primary endpoint as the group of patients was too mixed."
Hi PB, can you give us a little more colour behind that statement? It's the first I've heard of it although I admit I'm not that close to the medical community.
Sirt result, page-5
-
- There are more pages in this discussion • 79 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SRX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.5¢ |
Change
0.005(2.78%) |
Mkt cap ! $78.52M | |||
| Open | High | Low | Value | Volume |
| 18.5¢ | 18.5¢ | 18.0¢ | $20.49K | 111.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 36698734 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 3762780 | 11 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| SRX (ASX) Chart |